Thermo Fisher Scientific opens cell therapy facility at University of California
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
The company is addressing these observations
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The audit is a pre-approval inspection for three products filed from the facility
The observations are procedural in nature
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Proposed combination enhances Pfizer’s position as a leading company in oncology
The inspection concluded with no observations
Subscribe To Our Newsletter & Stay Updated